News Column

Stericycle, Inc. Reports Results for the Second Quarter and Year to Date 2014

July 24, 2014

LAKE FOREST, Ill., July 24, 2014 (GLOBE NEWSWIRE) -- Stericycle, Inc.(Nasdaq:SRCL), today reported financial results for the second quarter of 2014.

SECOND QUARTER RESULTS

Revenues for the quarter ended June 30, 2014 were $640.8 million, up $114.3 million or 21.7% from $526.5 million in the second quarter last year. Acquisitions contributed approximately $81.7 million to the current period's growth in revenues. Revenues increased 22.5% compared to the prior period when adjusted for unfavorable foreign exchange impact of $4.4 million. Gross profit was $275.3 million, up 15.7% from $237.9 million in the second quarter last year. Gross profit as a percent of revenues was 43.0% compared with 45.2% in the second quarter of 2013. Earnings per diluted share, reported in accordance with U.S. generally accepted accounting principles ("GAAP"), increased 7.0% to $0.95 from $0.89 in the second quarter last year. Non-GAAP earnings per diluted share, when adjusted for various items identified in the second of the following tables, increased 10.9% to $1.03 from $0.93. See tables below.

FIRST SIX MONTHS' RESULTS

Revenues for the six months ending June 30, 2014 were $1,210.8 million, up $170.4 million or 16.4% from $1,040.3 million in the same period last year. Acquisitions contributed approximately $114.6 million to the current year's growth in revenues. Revenues increased 17.6% compared with the prior period when adjusted for unfavorable foreign exchange impact of $12.4 million. Gross profit was $530.8 million, up 12.9% from $469.9 million in the same period last year. Gross profit as a percent of revenues was 43.8% compared with 45.2% in 2013. GAAP earnings per diluted share increased 7.0% to $1.87 from $1.74 in the same period last year. Non-GAAP earnings per diluted share, when adjusted for various items identified in the second of the following tables, increased 14.2% to $2.06 from $1.81. See tables below.

The following table shows our calculations of organic revenue growth (in millions)(1):

 Three Months Ended June 30,Six Months Ended June 30,
     Change    Change
 20142013$%20142013$%
Total As Reported Revenues (GAAP)$640.8$526.5$114.321.7%$1,210.8$1,040.3$170.416.4%
Adjustment for Foreign Exchange 4.4   4.4   12.4   12.4  
Subtotal (non-GAAP):645.2526.5118.722.5%1,223.21,040.3182.917.6%
                 
Adjustment for Acquisitions (84.3) (2.6) (81.7)   (119.5) (4.9) (114.6)  
Adjustment for Regulated Returns and Recall Management Services (24.7) (23.7) (1.0)   (47.8) (46.3) (1.5)  
Subtotal (non-GAAP):$536.1$500.2$35.97.2%$1,055.9$989.2$66.76.7%
                 
Domestic/ International Breakdown:                
Domestic Revenues$454.5$370.2$84.3 22.8%$846.5$733.8$112.7 15.4%
International Revenues 186.3 156.3 30.0 19.2% 364.3 306.5 57.7 18.8%
Total As Reported Revenues (GAAP)$640.8$526.5$114.321.7%$1,210.8$1,040.3$170.416.4%
 
(1) For internal purposes, we exclude the impact of foreign exchange and revenues attributed to acquisitions closed within the preceding 12 months and from our regulated returns and recall management services when we evaluate organic revenue growth. This table and the Company's internal use of non-GAAP adjusted revenues are not intended to imply, and should not be interpreted as implying, that non-GAAP adjusted revenues are a better measure of internal growth or the Company's performance, as compared to GAAP revenues.


Table to reconcile GAAP EPS to Non-GAAP EPS(2):

 Three Months Ended June 30,Six Months Ended June 30,
     Change    Change
 20142013$%20142013$%
GAAP EPS$0.95$0.89$0.067.0%$1.87$1.74$0.127.0%
                 
Acquisition Expenses 0.05 0.03     0.08 0.05    
Integration Expenses 0.04 0.01     0.06 0.02    
Change in Fair Value (0.01) --     0.05 --    
Litigation Settlement 0.00 0.00     0.01 0.00    
                 
Non-GAAP EPS (Adjusted)$1.03$0.93$0.1010.9%$2.06$1.81$0.2614.2%
 
(2) In accordance with GAAP, reported earnings per share (EPS) include the after-tax impact of the items identified in this table. For internal purposes, including the determination of management compensation, the Company excludes these items from results when evaluating operating performance. This table and the Company's internal use of non-GAAP earnings per share are not intended to imply, and should not be interpreted as implying, that non-GAAP earnings per share is a better measure of performance than GAAP earnings per share. 


Cash flow from operations was $238.3 million and $176.6 million for the six months ended June 30, 2014 and 2013, respectively.

For more information about Stericycle, please visit our website at www.stericycle.com.

Safe Harbor Statement: Statements in this press release may contain forward-looking statements that involve risks and uncertainties, some of which are beyond our control (for example, general economic conditions). Our actual results could differ significantly from the results described in the forward-looking statements. Factors that could cause such differences include changes in governmental regulation of medical waste collection and treatment and increases in transportation and other operating costs, as well as the other factors described in our filings with the U.S. Securities and Exchange Commission. As a result, past financial performance should not be considered a reliable indicator of future performance, and investors should not use historical trends to anticipate future results or trends. We make no commitment to disclose any subsequent revisions to forward-looking statements.

STERICYCLE, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
(IN THOUSANDS)
(UNAUDITED)
     
 June 30,December 31,
 20142013
ASSETS    
Current Assets:    
Cash and cash equivalents $ 25,326 $ 67,167
Short-term investments  488  413
Accounts receivable, net   451,995  388,996
Deferred income taxes  15,727  18,031
Prepaid expenses  33,288  28,379
Other current assets  40,051  37,279
Total Current Assets  566,875  540,265
Property, plant and equipment, net  480,419  358,967
Goodwill  2,421,348  2,231,582
Intangible assets, net  926,538  720,035
Other assets  42,101  37,124
Total Assets  $ 4,437,281  $ 3,887,973
     
LIABILITIES AND EQUITY    
Current Liabilities:    
Current portion of long-term debt  $ 151,289  $ 150,380
Accounts payable  125,392  89,146
Accrued liabilities  121,475  107,445
Deferred revenues  22,394  18,826
Other current liabilities  68,289  50,387
Total Current Liabilities  488,839  416,184
Long-term debt, net of current portion  1,563,913  1,280,663
Deferred income taxes  462,180  396,119
Other liabilities  70,006  27,469
Equity:    
Common stock  848  855
Additional paid-in capital  237,053  195,110
Accumulated other comprehensive loss  (45,554)  (56,468)
Retained earnings  1,634,875  1,610,964
Total Stericycle, Inc. Equity  1,827,222  1,750,461
Noncontrolling interests  25,121  17,077
Total Equity  1,852,343  1,767,538
Total Liabilities and Equity  $ 4,437,281  $ 3,887,973
     
     
STERICYCLE, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF INCOME
(IN THOUSANDS, EXCEPT SHARES AND PER SHARE DATA)
(UNAUDITED)
                 
 Three Months EndedSix Months Ended
 June 30,June 30,
 2014201320142013
  $ % of Rev $ % of Rev $ % of Rev $ % of Rev
                 
Revenues  $ 640,822 100.0%  $ 526,525 100.0%  $1,210,777 100.0%  $1,040,329 100.0%
Cost of revenues (exclusive of depreciation shown below)  350,416 54.7%  276,385 52.5%  652,176 53.9%  546,058 52.5%
Depreciation - cost of revenues  15,102 2.4%  12,288 2.3%  27,828 2.3%  24,325 2.3%
Total cost of revenues  365,518 57.0%  288,673 54.8%  680,004 56.2%  570,383 54.8%
Gross profit  275,304 43.0%  237,852 45.2%  530,773 43.8%  469,946 45.2%
                 
Selling, general and administrative expenses (exclusive of depreciation and amortization below)  109,329 17.1%  91,158 17.3%  209,509 17.3%  179,399 17.2%
Depreciation - SG&A  3,977 0.6%  2,954 0.6%  7,292 0.6%  5,763 0.6%
Amortization  8,402 1.3%  6,533 1.2%  15,717 1.3%  13,175 1.3%
Total SG&A expense  121,708 19.0%  100,645 19.1%  232,518 19.2%  198,337 19.1%
                 
Income from operations before acquisition, integration, and other expenses  153,596 24.0%  137,207 26.1%  298,255 24.6%  271,609 26.1%
                 
Acquisition expenses  3,979 0.6%  2,324 0.4%  7,200 0.6%  4,127 0.4%
Integration expenses  4,679 0.7%  1,383 0.3%  7,164 0.6%  2,279 0.2%
Change in fair value of contingent consideration  (836) -0.1%  (122) 0.0%  3,953 0.3%  (122) 0.0%
Litigation expenses  396 0.1%  (2) 0.0%  1,901 0.2%  104 0.0%
Restructuring and plant closure expenses  --  0.0%  104 0.0%  --  0.0%  104 0.0%
                 
Income from operations  145,378 22.7%  133,520 25.4%  278,037 23.0%  265,117 25.5%
                 
Other income (expense):                
Interest expense, net  (16,368) -2.6%  (12,913) -2.5%  (31,266) -2.6%  (26,292) -2.5%
Other expense, net  (392) -0.1%  (545) -0.1%  (1,092) -0.1%  (1,558) -0.1%
                 
Total other expense  (16,760) -2.6%  (13,458) -2.6%  (32,358) -2.7%  (27,850) -2.7%
                 
Income before income taxes  128,618 20.1%  120,062 22.8%  245,679 20.3%  237,267 22.8%
                 
Income tax expense  45,941 7.2%  41,619 7.9%  83,232 6.9%  83,602 8.0%
                 
Net income  82,677 12.9%  78,443 14.9%  162,447 13.4%  153,665 14.8%
                 
Less: net income attributable to noncontrolling interests  741 0.1%  399 0.1%  1,362 0.1%  1,004 0.1%
                 
Net income attributable to Stericycle, Inc.  $ 81,936 12.8%  $ 78,044 14.8%  $ 161,085 13.3%  $ 152,661 14.7%
                 
Earnings per share - diluted  $ 0.95    $ 0.89    $ 1.87    $ 1.74  
                 
Weighted average number of common shares outstanding - diluted  85,982,588    87,614,953    86,300,292    87,545,641  
                 
                 
STERICYCLE, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(IN THOUSANDS)
(UNAUDITED)
     
 Six Months Ended
 June 30,
 20142013
Operating Activities:    
Net income  $ 162,447  $ 153,665
Adjustments to reconcile net income to net cash provided by operating activities:    
Stock compensation expense  9,124  7,943
Excess tax benefit of stock options exercised  (7,080)  (8,373)
Depreciation  35,120  30,088
Amortization  15,717  13,175
Deferred income taxes  8,929  13,101
Change in fair value of contingent consideration  3,953  (122)
Changes in operating assets and liabilities, net of effect of acquisitions and divestitures:    
Accounts receivable  (9,606)  (42,871)
Accounts payable  10,646  10,186
Accrued liabilities  (6,809)  (2,566)
Deferred revenue  2,332  (548)
Other assets and liabilities  13,575  2,903
     
Net cash provided by operating activities  238,348  176,581
     
Investing Activities:    
Payments for acquisitions, net of cash acquired  (304,832)  (63,401)
(Purchases of)/ proceeds from investments  (2,052)  33
Capital expenditures  (43,668)  (37,441)
     
Net cash used in investing activities  (350,552)  (100,809)
     
Financing Activities:    
Repayments of long-term debt and other obligations  (28,005)  (32,016)
Borrowings on foreign bank debt  96,828  92,733
Repayments on foreign bank debt  (85,192)  (96,512)
Borrowings on senior credit facility  933,101  527,469
Repayments on senior credit facility  (732,059)  (544,183)
Payments on capital lease obligations  (1,993)  (1,825)
Payments of deferred financing costs  (2,280)  -- 
Purchases and cancellations of treasury stock  (137,186)  (66,175)
Proceeds from issuances of common stock  21,195  23,667
Excess tax benefit of stock options exercised  7,080  8,373
Payments to noncontrolling interests  (732)  -- 
     
Net cash provided by/ (used) in financing activities  70,757  (88,469)
Effect of exchange rate changes on cash  (394)  (528)
Net decrease in cash and cash equivalents  (41,841)  (13,225)
Cash and cash equivalents at beginning of period  67,167  34,659
     
Cash and cash equivalents at end of period  $ 25,326  $ 21,434
     
Non-cash activities:    
Issuances of obligations for acquisitions  $ 83,864  $ 22,906
     

CONTACT: Frank ten Brink 847-607-2012



Stericycle, Inc. logo

Source: Stericycle, Inc.


For more stories on investments and markets, please see HispanicBusiness' Finance Channel



Source: GlobeNewswire


Story Tools






HispanicBusiness.com Facebook Linkedin Twitter RSS Feed Email Alerts & Newsletters